This website provides information about laboratory diagnostic services. The analyses presented are not therapeutic and do not replace medical diagnosis and treatment. Medical decisions are made exclusively by your treating physician.
Gene expression analysis tumor diagnostics revolutionizes modern oncology through precise decoding of genetic activity patterns in cancer tissue. Gene expression analysis cancer diagnostics, rna sequencing tumor diagnostics, transcriptome analysis tumor diagnostics, biomarker profiling tumor diagnostics and expression patterns tumor diagnostics enable a completely new dimension of tumor characterization at the molecular level.
RNA sequencing cancer diagnostics uses state-of-the-art next-generation sequencing technologies for detailed analysis of gene activity. Transcriptome analysis cancer diagnostics identifies specific expression profiles characteristic of different tumor subtypes. With biomarker profiling cancer diagnostics, oncologists can now determine therapeutic targets with unprecedented accuracy.
Expression patterns cancer diagnostics create the foundation for personalized treatment strategies and enable precise prognosis based on individual tumor biology.
Personalized cancer diagnostics
Insights into the latest developments in personalized diagnostics
How gene expression analysis is revolutionizing tumour diagnostics
Cancer is still the number one cause of death in people under the age of 70 – a frightening statistic that affects us all. But modern medicine offers new hope: our RNA gene expression diagnostics support the selection of the most promising individual therapies, taking into account all current tumor treatment options.
RNA Sequencing Tumor Diagnostics – High-Resolution Gene Activity Analysis
RNA sequencing tumor diagnostics enables comprehensive analysis of all active genes in tumor cells with single-cell resolution. RNA sequencing cancer diagnostics identifies characteristic transcription profiles that define specific tumor types and subtypes. With rna sequencing tumor diagnostics, researchers can now precisely track dynamic changes in gene expression during tumor development and identify therapeutic targets.
Transcriptome Analysis Tumor Diagnostics – Decoding Complete RNA Landscape
Transcriptome analysis tumor diagnostics provides a complete picture of all RNA molecules in tumor cells for comprehensive molecular characterization. Transcriptome analysis cancer diagnostics combines different RNA types like mRNA, microRNA and long non-coding RNA for holistic tumor profiling. These transcriptome analysis tumor diagnostics approaches enable discovery of new biomarkers and development of targeted therapy strategies based on individual tumor RNA signatures.
Biomarker Profiling Tumor Diagnostics – Identifying Therapeutic Targets
Biomarker profiling tumor diagnostics uses expression data to identify prognostic and predictive biomarkers for personalized treatment approaches. Biomarker profiling cancer diagnostics integrates machine learning and artificial intelligence for pattern recognition in complex gene expression data. With biomarker profiling tumor diagnostics, clinicians can now predict therapy response and detect resistance mechanisms early.
Expression Patterns Tumor Diagnostics – Tumor Signatures for Precision Medicine
Expression patterns tumor diagnostics analyzes characteristic gene activity profiles for exact tumor classification and prognosis. Expression patterns cancer diagnostics enables development of molecular tumor subtypes that go beyond morphological classifications. These expression patterns tumor diagnostics procedures create the foundation for a new generation of personalized cancer medicine with tailored treatment protocols.
The vision
A world in which cancer can be chronicled
In the following video presentation from the 2nd iQMedix Medical Congress, you will learn first-hand how gene expression analysis is revolutionizing tumour diagnostics and what groundbreaking possibilities it opens up for personalized cancer therapy. The presentation will show how modern Liquid Biopsy methods and targeted gene expression analyses can already fundamentally improve the treatment of cancer patients.
The vision is clearly defined: A world in which cancer becomes a chronic disease, using state-of-the-art personalized RNA gene expression diagnostics and new therapeutic approaches to give every patient hope and more time to live in better health.
Liquid Biopsy
A paradigm shift in cancer diagnostics
Why is Liquid Biopsy so revolutionary?
Traditional tissue sampling (biopsy) is often invasive and not always feasible. Liquid Biopsy, on the other hand, offers a 10 to 100 times more sensitive method for detecting malignancies and measuring the incidence of MRD (Minimal Residual Disease).
Understanding the four stages of cancer development
Stage 1
Local tumor
Stage 2
Locally advanced tumor
Stage 3
Lymph node infestation
Stage 4
Metastasized tumor
“Early diagnosis is the key to successful
tumor management. It can save lives and increase the
chances of maintaining long-term health.
Comprehensive diagnostics: more than just blood
Wide range of sample materials for precise results
iQMedix can not only analyze blood samples, but also:
- Sputum (lung area)
- Urine (urogenital area)
- Tissue (direct tumor analysis)
- Cerebrospinal fluid (brain)
From circulating tumor cells to precise tumor information
The process begins with the isolation of CTCs from blood and leads to valuable diagnostic information in several steps:
- Isolation of circulating tumor cells from the blood
- Extraction of mRNA, synthesis of cDNA
- Measurement of 85+ gene expressions using qPCR
- Analysis of expression patterns and assignment of therapy options
Personalized therapy options:
Precision instead of a watering can principle
Gene expression analysis as a compass
“Measuring the gene expression profile reveals, among other things, highly expressed genes that indicate in which areas the tumor is particularly active.
More importantly, the signals indicate which therapies could be successful and which less so.”
Comprehensive therapy options
The modern treatment spectrum includes a wide range of available approaches:
Complementary substances include, among others:
- Berberine, Boswellia, Curcumin
- Sulforaphane, resveratrol
- Vitamin C, Artesunate
- And many other natural active ingredients and off-label medicines
Pharmaceutical therapeutics include:
- Cytostatics
- Hormone therapeutics
- Kinase inhibitors
- And many other targeted drugs
The treatment path
The treatment path: from diagnosis to personalized therapy
iSELECT and iComplete: two pillars of diagnostics
iSELECT
For patients in the early stages:
- Natural substances and off-label substances
- Focus on complementary substances for optimal results
iCOMPLETE
For patients in advanced stages:
- Comprehensive diagnostics
- Determination of the most promising therapy for the individual case
What can Liquid Biopsy actually do?
- Painless biopsy often also for tumors that are difficult to access (brain, lungs, etc.)
- Comprehensive tumor screening from almost all parts of the body
- Highly sensitive and early molecular detection of malignant diseases
- Identification of individual therapeutic goals with maximum effect and minimum side effects
- Painless therapeutic tracking and indications of the development of resistance
The future of cancer treatment is personalized
The latest developments make it clear that we are on the threshold of a new era in cancer treatment. By combining Liquid Biopsy with gene expression analysis and personalized therapy approaches, we can not only frequently improve the chances of survival, but often also significantly increase patients’ quality of life.
The vision of iQMedix – to transform cancer from a fatal to a chronic, manageable disease – is no longer just a dream, but can become a tangible reality thanks to innovative diagnostics and individualized treatment concepts.
